At 18.1% CAGR, Next Generation Sequencing Market to Reach Beyond US$ 21.3 Billion by 2027 | Growing Demand of NGS Platforms in Upcoming Years

Next Generation Sequencing (NGS) is a powerful, flexible, and indispensable biological tool that is used in several areas of biological study. NGS technologies help in generating genome-wide sequence data in a couple of days. These technologies are highly parallelized allowing to sequence thousands to millions of molecules at the same time. The main advantage of these platforms is determination of the sequenced data from amplified single DNA fragments, avoiding the need for cloning of DNA fragments.

Request a sample copy @
https://www.coherentmarketinsights.com/insight/request-sample/158

NGS has large number of applications, enabling rapid technological advances across several fields in biological science. The technology has enabled researchers to gain significant knowledge in public health studies and epidemiology, to sequence viruses and bacteria and help detect causes that may contribute to virulence. Furthermore, in gene expression research, next generation sequencing of RNA replace microarray analysis, allowing researchers to see RNA expression sequence. This RNA sequencing can provide information on entire transcriptome in one analysis, irrespective of any previous knowledge of genetic sequence.

NGS technologies along with bioinformatics analysis are increasingly used to simultaneously study multiple genes in a time and cost-effective manner and have been useful in analyzing clinical cancer samples and molecular diagnosis. The technology is a useful tool for diagnosis of a number of cancers. Furthermore, increasing incidence of Alzheimer’s and other hereditary diseases is contributing to growth of the exome sequencing segment in the next generation sequencing market. According to World Alzheimer Report in 2016, an estimated 46.5 million people were suffering from Alzheimer’s disease and the number is projected to reach 50 million in 2017.

PDF Brochure Of This Report @
https://www.coherentmarketinsights.com/insight/request-pdf/158

Detailed Segmentation:

Global Next Generation Sequencing Market, By Technology:
Whole Genome Sequencing
Whole Exome Sequencing
RNA Sequencing
Targeted Re-sequencing
Others
Global Next Generation Sequencing Market, By Application:
Drug Discovery
Personalized Medicine and Genetic Screening
Disease Diagnosis
Agriculture and Animal Research
Others
Global Next Generation Sequencing Market, By End User:
Hospital
Research Centers
Pharma and Biotech Firms
Others

Apply Promo Code “STAYHOME” and Get FLAT 20% Discount

Buy This Complete A Business Report:
https://www.coherentmarketinsights.com/insight/buy-now/158

Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.